BUZZ-Altimmune falls as CEO Vipin Garg to step down
Shares of drug developer Altimmunefall 6.7% to $4.91 premarketCo says Chairman Jerry Durso will take over as chief executive officer on January 1, 2026, succeeding Vipin Garg, who has led the company for seven yearsCo says Durso previously led Intercept Pharmaceuticals and spent over 20 years at Sanofi (SASY.PA) Co’s lead drug pemvidutide is being developed for liver disease and weight loss - ALTALT expects 48-week mid-stage trial data and FDA meeting on proposed late-stage study before year-end, co saysUp to last close, stock down ~27% YTD
Shares of drug developer Altimmune (ALT.O) fall 6.7% to $4.91 premarket
Co says Chairman Jerry Durso will take over as chief executive officer on January 1, 2026, succeeding Vipin Garg, who has led the company for seven years
Co says Durso previously led Intercept Pharmaceuticals and spent over 20 years at Sanofi (SASY.PA)
Co’s lead drug pemvidutide is being developed for liver disease and weight loss - ALT
ALT expects 48-week mid-stage trial data and FDA meeting on proposed late-stage study before year-end, co says
Up to last close, stock down ~27% YTD
